Moderna names Catalent as manufacturing partner for potential COVID-19 vaccine

This post was originally published on this site

Under the deal, Catalent would also provide packaging and labeling, storage and distribution services to support Moderna’s late-stage clinical trial for the vaccine. (https://reut.rs/384fCLt)

Add Comment